Free Trial

Investors Buy High Volume of Put Options on Bath & Body Works (NYSE:BBWI)

Bath & Body Works logo with Retail/Wholesale background

Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report) was the target of some unusual options trading activity on Wednesday. Stock traders bought 18,630 put options on the stock. This is an increase of 178% compared to the average volume of 6,690 put options.

Bath & Body Works Price Performance

BBWI traded down $0.46 during mid-day trading on Thursday, hitting $26.58. The stock had a trading volume of 5,164,408 shares, compared to its average volume of 4,994,008. The stock's fifty day simple moving average is $29.80 and its 200-day simple moving average is $33.85. The firm has a market capitalization of $5.62 billion, a price-to-earnings ratio of 6.48, a price-to-earnings-growth ratio of 0.92 and a beta of 1.72. Bath & Body Works has a 1-year low of $24.96 and a 1-year high of $47.48.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Thursday, May 29th. The company reported $0.49 EPS for the quarter, topping analysts' consensus estimates of $0.47 by $0.02. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.42 billion. During the same period last year, the business posted $0.38 earnings per share. The firm's quarterly revenue was up 2.9% on a year-over-year basis. As a group, research analysts expect that Bath & Body Works will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works announced that its Board of Directors has initiated a stock repurchase plan on Thursday, February 27th that allows the company to repurchase $500.00 million in outstanding shares. This repurchase authorization allows the company to repurchase up to 6.4% of its stock through open market purchases. Stock repurchase plans are often a sign that the company's management believes its shares are undervalued.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 20th. Investors of record on Friday, June 6th will be issued a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, June 6th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.01%. Bath & Body Works's payout ratio is 21.33%.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. Telsey Advisory Group reissued an "outperform" rating and set a $38.00 price target (down from $43.00) on shares of Bath & Body Works in a research note on Thursday, May 29th. Wells Fargo & Company increased their price objective on shares of Bath & Body Works from $40.00 to $44.00 and gave the company an "overweight" rating in a report on Wednesday, May 14th. Barclays cut their price objective on shares of Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating on the stock in a report on Friday, May 30th. Cowen restated a "buy" rating on shares of Bath & Body Works in a report on Thursday, February 27th. Finally, The Goldman Sachs Group cut their price objective on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating on the stock in a report on Friday, May 30th. Four equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $42.00.

View Our Latest Stock Analysis on Bath & Body Works

Institutional Investors Weigh In On Bath & Body Works

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. SRS Capital Advisors Inc. increased its stake in Bath & Body Works by 99.7% in the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock valued at $26,000 after buying an additional 329 shares during the last quarter. Northwest Bank & Trust Co increased its stake in Bath & Body Works by 2.9% in the 4th quarter. Northwest Bank & Trust Co now owns 14,700 shares of the company's stock valued at $533,000 after buying an additional 419 shares during the last quarter. Lindbrook Capital LLC increased its stake in Bath & Body Works by 81.9% in the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock valued at $37,000 after buying an additional 431 shares during the last quarter. Cornerstone Investment Partners LLC increased its stake in Bath & Body Works by 3.8% in the 4th quarter. Cornerstone Investment Partners LLC now owns 12,248 shares of the company's stock valued at $475,000 after buying an additional 452 shares during the last quarter. Finally, Nicolet Bankshares Inc. increased its stake in Bath & Body Works by 2.8% in the 4th quarter. Nicolet Bankshares Inc. now owns 17,232 shares of the company's stock valued at $668,000 after buying an additional 463 shares during the last quarter. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

(Get Free Report)

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Read More

Should You Invest $1,000 in Bath & Body Works Right Now?

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines